These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Maass AH; Ikeda K; Oberdorf-Maass S; Maier SK; Leinwand LA Circulation; 2004 Oct; 110(15):2102-9. PubMed ID: 15466629 [TBL] [Abstract][Full Text] [Related]
4. IMAGE CARDIO MED: Inducible malignant ventricular tachyarrhythmia in a patient with genotyped hypertrophic cardiomyopathy in absence of left ventricular hypertrophy or enlargement. Ariyarajah V; Tam JW; Khadem A Circulation; 2009 Jun; 119(21):e543-4. PubMed ID: 19487599 [No Abstract] [Full Text] [Related]
5. The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. Semsarian C; Ahmad I; Giewat M; Georgakopoulos D; Schmitt JP; McConnell BK; Reiken S; Mende U; Marks AR; Kass DA; Seidman CE; Seidman JG J Clin Invest; 2002 Apr; 109(8):1013-20. PubMed ID: 11956238 [TBL] [Abstract][Full Text] [Related]
6. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure. Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356 [TBL] [Abstract][Full Text] [Related]
7. Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependant severity. Stefanelli CB; Rosenthal A; Borisov AB; Ensing GJ; Russell MW Mol Genet Metab; 2004; 83(1-2):188-96. PubMed ID: 15464434 [TBL] [Abstract][Full Text] [Related]
8. A contemporary approach to hypertrophic cardiomyopathy. Ho CY; Seidman CE Circulation; 2006 Jun; 113(24):e858-62. PubMed ID: 16785342 [No Abstract] [Full Text] [Related]
9. Advances in medical treatment of hypertrophic cardiomyopathy. Hamada M; Ikeda S; Shigematsu Y J Cardiol; 2014 Jul; 64(1):1-10. PubMed ID: 24735741 [TBL] [Abstract][Full Text] [Related]
10. [Clinical and hemodynamic effects of diltiazem in patients with arterial hypertension associated with ischemic heart disease]. Bychko MV Lik Sprava; 2007; (1-2):50-5. PubMed ID: 17682517 [TBL] [Abstract][Full Text] [Related]
12. Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy. Tsoutsman T; Kelly M; Ng DC; Tan JE; Tu E; Lam L; Bogoyevitch MA; Seidman CE; Seidman JG; Semsarian C Circulation; 2008 Apr; 117(14):1820-31. PubMed ID: 18362229 [TBL] [Abstract][Full Text] [Related]
13. Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy. Knollmann BC; Blatt SA; Horton K; de Freitas F; Miller T; Bell M; Housmans PR; Weissman NJ; Morad M; Potter JD J Biol Chem; 2001 Mar; 276(13):10039-48. PubMed ID: 11113119 [TBL] [Abstract][Full Text] [Related]
14. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy. Tsoutsman T; Chung J; Doolan A; Nguyen L; Williams IA; Tu E; Lam L; Bailey CG; Rasko JE; Allen DG; Semsarian C J Mol Cell Cardiol; 2006 Oct; 41(4):623-32. PubMed ID: 16950368 [TBL] [Abstract][Full Text] [Related]
15. Independent FHC-related cardiac troponin T mutations exhibit specific alterations in myocellular contractility and calcium kinetics. Haim TE; Dowell C; Diamanti T; Scheuer J; Tardiff JC J Mol Cell Cardiol; 2007 Jun; 42(6):1098-110. PubMed ID: 17490679 [TBL] [Abstract][Full Text] [Related]